Here, we showed that ST2+ Treg cells that are non-engineered and non-professional cytotoxic T cells are equipped with high levels of GZMB (up to 40%) and can directly kill leukemia-primed effector T cells at a low ratio of 1:1 to promote tumor progression, adding a second mechanism of suppression. This evidence concerns the gene IL1RL1 and leukemia.